Logo image of BHRB

BURKE & HERBERT FINANCIAL SE (BHRB) Stock Fundamental Analysis

USA - NASDAQ:BHRB - US12135Y1082 - Common Stock

60.18 USD
+1.43 (+2.43%)
Last: 10/20/2025, 8:00:01 PM
60.18 USD
0 (0%)
After Hours: 10/20/2025, 8:00:01 PM
Fundamental Rating

4

Overall BHRB gets a fundamental rating of 4 out of 10. We evaluated BHRB against 391 industry peers in the Banks industry. Both the profitability and financial health of BHRB have multiple concerns. BHRB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BHRB had positive earnings in the past year.
In the past year BHRB had a positive cash flow from operations.
In the past 5 years BHRB has always been profitable.
BHRB had a positive operating cash flow in each of the past 5 years.
BHRB Yearly Net Income VS EBIT VS OCF VS FCFBHRB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

With a Return On Assets value of 0.72%, BHRB perfoms like the industry average, outperforming 40.92% of the companies in the same industry.
BHRB has a Return On Equity of 7.49%. This is comparable to the rest of the industry: BHRB outperforms 43.22% of its industry peers.
Industry RankSector Rank
ROA 0.72%
ROE 7.49%
ROIC N/A
ROA(3y)0.77%
ROA(5y)0.82%
ROE(3y)9.37%
ROE(5y)8.85%
ROIC(3y)N/A
ROIC(5y)N/A
BHRB Yearly ROA, ROE, ROICBHRB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BHRB has a worse Profit Margin (17.83%) than 68.29% of its industry peers.
BHRB's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for BHRB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 17.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-25.05%
PM growth 5Y-3.31%
GM growth 3YN/A
GM growth 5YN/A
BHRB Yearly Profit, Operating, Gross MarginsBHRB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

BHRB does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHRB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BHRB has been increased compared to 5 years ago.
BHRB has a better debt/assets ratio than last year.
BHRB Yearly Shares OutstandingBHRB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
BHRB Yearly Total Debt VS Total AssetsBHRB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BHRB has a debt to FCF ratio of 3.74. This is a good value and a sign of high solvency as BHRB would need 3.74 years to pay back of all of its debts.
BHRB has a Debt to FCF ratio of 3.74. This is in the lower half of the industry: BHRB underperforms 62.92% of its industry peers.
BHRB has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.15, BHRB perfoms like the industry average, outperforming 56.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.74
Altman-Z N/A
ROIC/WACCN/A
WACC14.29%
BHRB Yearly LT Debt VS Equity VS FCFBHRB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BHRB Yearly Current Assets VS Current LiabilitesBHRB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

BHRB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.67%, which is quite impressive.
The earnings per share for BHRB have been decreasing by -49.41% on average. This is quite bad
The Revenue has grown by 191.97% in the past year. This is a very strong growth!
Measured over the past years, BHRB shows a quite strong growth in Revenue. The Revenue has been growing by 19.52% on average per year.
EPS 1Y (TTM)29.67%
EPS 3Y-16.68%
EPS 5Y-49.41%
EPS Q2Q%159.27%
Revenue 1Y (TTM)191.97%
Revenue growth 3Y32.02%
Revenue growth 5Y19.52%
Sales Q2Q%214.61%

3.2 Future

Based on estimates for the next years, BHRB will show a small growth in Earnings Per Share. The EPS will grow by 6.76% on average per year.
BHRB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.10% yearly.
EPS Next Y10.83%
EPS Next 2Y6.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.14%
Revenue Next 2Y16.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BHRB Yearly Revenue VS EstimatesBHRB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BHRB Yearly EPS VS EstimatesBHRB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.12, BHRB is valued correctly.
Based on the Price/Earnings ratio, BHRB is valued a bit more expensive than the industry average as 70.08% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.69. BHRB is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 7.71 indicates a rather cheap valuation of BHRB.
Based on the Price/Forward Earnings ratio, BHRB is valued cheaper than 84.91% of the companies in the same industry.
BHRB is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.12
Fwd PE 7.71
BHRB Price Earnings VS Forward Price EarningsBHRB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BHRB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BHRB is cheaper than 80.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.11
EV/EBITDA N/A
BHRB Per share dataBHRB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

BHRB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y6.76%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

BHRB has a Yearly Dividend Yield of 3.79%. Purely for dividend investing, there may be better candidates out there.
BHRB's Dividend Yield is a higher than the industry average which is at 3.57.
BHRB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.79%

5.2 History

The dividend of BHRB decreases each year by -49.11%.
BHRB has paid a dividend for at least 10 years, which is a reliable track record.
BHRB has decreased its dividend recently.
Dividend Growth(5Y)-49.11%
Div Incr Years1
Div Non Decr Years1
BHRB Yearly Dividends per shareBHRB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5.3 Sustainability

BHRB pays out 58.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.38%
EPS Next 2Y6.76%
EPS Next 3YN/A
BHRB Yearly Income VS Free CF VS DividendBHRB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BHRB Dividend Payout.BHRB Dividend Payout, showing the Payout Ratio.BHRB Dividend Payout.PayoutRetained Earnings

BURKE & HERBERT FINANCIAL SE

NASDAQ:BHRB (10/20/2025, 8:00:01 PM)

After market: 60.18 0 (0%)

60.18

+1.43 (+2.43%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-23 2025-10-23
Inst Owners37.36%
Inst Owner Change-0.23%
Ins Owners11.03%
Ins Owner Change4.47%
Market Cap903.90M
Analysts84.44
Price Target73.1 (21.47%)
Short Float %1.63%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield 3.79%
Yearly Dividend2.56
Dividend Growth(5Y)-49.11%
DP58.38%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-15 2025-08-15 (0.55)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.39%
Min EPS beat(2)-2.51%
Max EPS beat(2)-0.27%
EPS beat(4)1
Avg EPS beat(4)-52.42%
Min EPS beat(4)-208.85%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.6%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)-2.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.69%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)8.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.41%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 15.12
Fwd PE 7.71
P/S 2.84
P/FCF 8.11
P/OCF 7.77
P/B 1.19
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)3.98
EY6.61%
EPS(NY)7.81
Fwd EY12.97%
FCF(TTM)7.42
FCFY12.34%
OCF(TTM)7.75
OCFY12.87%
SpS21.21
BVpS50.47
TBVpS44.75
PEG (NY)1.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 7.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.83%
GM N/A
FCFM 35%
ROA(3y)0.77%
ROA(5y)0.82%
ROE(3y)9.37%
ROE(5y)8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-25.05%
PM growth 5Y-3.31%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.74
Debt/EBITDA N/A
Cap/Depr 21.44%
Cap/Sales 1.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 196.34%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC14.29%
ROIC/WACCN/A
Cap/Depr(3y)426.06%
Cap/Depr(5y)280.76%
Cap/Sales(3y)11.2%
Cap/Sales(5y)7.41%
Profit Quality(3y)147.57%
Profit Quality(5y)133.78%
High Growth Momentum
Growth
EPS 1Y (TTM)29.67%
EPS 3Y-16.68%
EPS 5Y-49.41%
EPS Q2Q%159.27%
EPS Next Y10.83%
EPS Next 2Y6.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)191.97%
Revenue growth 3Y32.02%
Revenue growth 5Y19.52%
Sales Q2Q%214.61%
Revenue Next Year30.14%
Revenue Next 2Y16.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y187.45%
FCF growth 3Y14.67%
FCF growth 5Y27.71%
OCF growth 1Y101.84%
OCF growth 3Y16.01%
OCF growth 5Y27.29%